Mutations |
1 mutations
Species: mouse
Mutation name: None
type: null mutation
fertility: subfertile
Comment: Koomen M, et al reported that reduced fertility and hypersensitivity to mitomycin C characterize Fancg/Xrcc9 null mice.
Fanconi anemia (FA) is a heterogeneous autosomal recessive chromosomal instability syndrome associated with
diverse developmental abnormalities, progressive bone marrow failure and a predisposition to cancer.
Spontaneous chromosomal breakage and hypersensitivity to DNA cross-linking agents characterize the cellular
FA phenotype. The gene affected in FA complementation group G patients was initially identified as XRCC9, for
its ability to partially correct the cellular phenotype of the Chinese hamster ovary (CHO) cell mutant UV40. By
targeted disruption we generated Fancg/Xrcc9 null mice. Fancg knock-out (KO) mice were born at expected
Mendelian frequencies and showed normal viability. In mice, functional loss of Fancg did not result in
developmental abnormalities or a pronounced incidence of malignancies. During a 1 year follow-up, blood cell
parameters of Fancg KO mice remained within normal values, revealing no signs of anemia. Male and female
mice deficient in Fancg showed hypogonadism and impaired fertility, consistent with the phenotype of FA
patients. Mouse embryonic fibroblasts (MEFs) from the KO animals exhibited the FA characteristic cellular
response in showing enhanced spontaneous chromosomal instability and a hyper-responsiveness to the
clastogenic and antiproliferative effects of the cross-linking agent mitomycin C (MMC). The sensitivity to UV,
X-rays and methyl methanesulfonate, reported for the CHO mutant cell line UV40, was not observed in
Fancg(--/--) MEFs. Despite a lack of hematopoietic failure in the KO mice, clonogenic survival of bone marrow
cells in vitro was strongly reduced in the presence of MMC. The characteristics of the Fancg(--/--) mice closely
resemble those reported for Fancc and Fanca null mice, supporting a tight interdependence of the corresponding
gene products in a common pathway.
|